Claritas Rx LLC

Claritas Rx is a healthcare technology company that provides data integration and analytics solutions for biopharmaceutical manufacturers. Headquartered in South San Francisco, California, the company's core mission is to remove barriers that prevent patients from accessing and adhering to necessary treatments, particularly within the specialty and rare disease sectors. It achieves this by transforming fragmented patient data into cohesive, actionable intelligence to optimize the entire patient journey.

The company offers a cloud-hosted Software-as-a-Service (SaaS) platform, Ascend®, which integrates real-world specialty data with advanced analytics, artificial intelligence (AI), and intelligent case management. Key solutions within its suite include Foundational Data Aggregation (featuring Consent Clearinghouse™), Access Analytics, Patient Watchtower™, Patient Services Omnichannel CRM, and Performance Benchmarking. These tools are designed to help biopharma companies optimize market access strategies, strengthen channel partnership management, and enhance patient access and outcomes for specialty, rare disease, and cell & gene therapies.

Claritas Rx has recently garnered industry recognition, including the Fierce AI Innovation Award for its Omnichannel Engagement Strategy, specifically for its Patient Watchtower™ and Patient Services Omnichannel CRM solutions. The company was also named to the Inc. 5000 list for the second consecutive year in 2026, coinciding with its 15th year in business. Led by CEO and Founder Mike Fitzgibbons, Claritas Rx strengthened its executive team in May 2026 with new appointments, including Keith Pensabene as Chief Revenue Officer. The company positions itself as an expert in the patient journey, delivering real-time insights and solutions to foster seamless support and improved outcomes for biopharmaceutical clients.